Thymosin Alpha-1
10mg/vial
Immunomodulatory thymic peptide studied for T-cell activation, innate immune priming, and inflammatory regulation.
Price per vial
$149.99
10mg/vial
Concentration
10mg/vial
Warehouse
US Domestic
Product Description
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide originally isolated from thymosin fraction 5 of bovine thymus tissue. It is one of the most studied immunomodulatory peptides, with decades of research spanning infectious disease, oncology, and autoimmune models.
Research Overview
Tα1 acts primarily through Toll-like receptor (TLR) signaling and dendritic cell activation, promoting Th1-dominant immune responses and enhancing natural killer (NK) cell activity. Research has examined its role in restoring immune competence in immunocompromised models, augmenting vaccine efficacy, and modulating inflammatory cytokine profiles. It has been investigated in models of chronic viral infection, sepsis, and cancer immunotherapy adjuvancy. For laboratory research use only.
Research Applications
Research Use Only
This product is intended solely for laboratory research and analytical purposes. Not for human consumption or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA.